dmLT

double-mutant Escherichia coli heat-labile toxin (dmLT) · National Institute of Allergy and Infectious Diseases (NIAID)

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for dmLT, covering 2022-01-18 to 2022-01-18. Get the full timeline:

Most recent: Clinical Trial Update: A Double-Blind Placebo-Control Dose Escalating Study to Evaluate the Safety and Immunogenicity of dmLT by Oral, Sublingual and Intradermal Vaccination in Adults Residing in an Endemic Area [Phase 1]

See pricing